MedPath

Ehime Study - Effect of Azilsartan on Home Blood Pressure

Not Applicable
Conditions
essential hypertension
Registration Number
JPRN-UMIN000011936
Lead Sponsor
Department of Cardiology, Pulmonology, Hypertension & Nephrology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients with hypersensitivity reaction to azilsartan. 2.Patients with hypersensitivity reaction to dihydropyridine-based compound. 3.Pregnant or nursing mothers. 4.Patients who takes antihypertensive drugs except for angiotensin receptor blockers. 5.Patients with myocardial infarction, heart failure, or stroke within 6 months. 6.Patients withserum creatinine concentration 1.2 mg/dL and over. 7.Patients with elevated liver enzymes (AST or ALT 40 IU/L and over) 8.Patients with systolic blood pressure 180 mmHg and over or diastolic blood pressure 110 mmHg and over.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The difference of blood pressure lowering effect between azilsartan and amlodipine
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath